GRPR and neoplasm: For example, [111In]In-SB4, where Gly11 is replaced by DAla11, despite its high in vivo metabolic stability demonstrated lower GRPR-affinity and cell uptake, eventually translating into an inferior tumor uptake compared with the unmodified parent [111In]In-SB3 [38].